The imperative to transport therapeutic molecules across cellular membranes has compelled researchers at the University of Stuttgart to engineer a groundbreaking solution that merges the precision of DNA nanotechnology with the complexity of synthetic biology. Published in Nature Materials on January 13, 2025, the work demonstrates how reconfigurable DNA nanostructures, termed nanorafts, may fundamentally alter the morphology and permeability of artificial cell membranes, thereby opening novel pathways for targeted therapeutic interventions.
The principle governing this innovation reflects the architectural maxim whereby form follows function—a concept that permeates biological systems at every scale, from the nanometer to the micron. Professor Laura Na Liu and her collaborators constructed a synthetic cell model comprising three integrated components: signal-responsive DNA origami nanorafts, bacterial outer membrane proteins (OmpF), and giant unilamellar vesicles (GUVs) that mimic natural lipid bilayers. The DNA nanorafts, fashioned through the intricate folding of DNA strands via specifically designed staple sequences, undergo dramatic conformational transitions. These structures shift from nearly square configurations (aspect ratio approximately 1.3) to elongated rectangular forms (aspect ratio approximately 9.5) when triggered by toehold-mediated strand-displacement reactions.
The significance lies not merely in the nanorafts’ capacity for shape modification but in their ability to orchestrate microscale cellular remodeling. When these DNA structures reconfigure upon the GUV membrane, they collectively transition from disordered arrangements to short-range tetratic order, thereby inducing corresponding morphological changes in the vesicles themselves. During the recovery phase, the locally ordered nanorafts—assisted by the biogenic pores—perforate the lipid membrane, forming sealable synthetic channels sufficiently large to permit the passage of therapeutic proteins and enzymes across the membrane barrier.
This platform represents a milestone in synthetic biology’s pursuit of functional artificial cells. Unlike biological transport mechanisms constrained by evolutionary architecture, these DNA nanorobots operate through fully synthetic pathways devoid of direct biological equivalents in living systems. The channels they create are programmable, reversible, and scalable, offering unprecedented control over cargo flux into cellular compartments. Such attributes suggest potential applications extending beyond fundamental research into the realm of precision medicine, where the targeted delivery of large therapeutic molecules remains a persistent challenge. The work intimates that molecular-scale engineering may provide solutions less complex than their biological counterparts yet equally effective in biological environments, thereby advancing both our understanding of membrane dynamics and our capacity to manipulate cellular behavior for therapeutic purposes.
Leave a Reply